University of Antwerp-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Lockdown, Earnings Losses and Household Asset Buffers in Europe1

    Review of Income and Wealth, Vol. 68, Núm. 2, pp. 428-470

2016

  1. Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366